Mycoplasma Testing Market: Global Market Size, Growth Trends, and Forecast

The Mycoplasma Testing Market is witnessing strong growth as pharmaceutical and biotechnology companies place greater emphasis on contamination control, product quality, and regulatory compliance.

According to Market Research Future, the global market was valued at approximately USD 1.21 billion in 2025 and is projected to reach USD 3.52 billion by 2035, expanding at a CAGR of 10.20% during 2026–2035.

Mycoplasma testing plays an essential role in detecting contamination in cell cultures, biologics, vaccines, and biopharmaceutical manufacturing processes. Increasing production of biologics and the expansion of cell and gene therapy pipelines are generating additional demand for reliable contamination detection technologies.

The market is also benefiting from the transition from traditional culture-based testing toward faster molecular techniques. PCR-based testing, particularly quantitative PCR, is increasingly used because it can provide results significantly faster than conventional culture methods.

North America currently represents the largest regional market, supported by a well-established biopharmaceutical manufacturing industry and strong regulatory requirements. Asia-Pacific is expected to record rapid growth as biomanufacturing capacity expands across China, India, Singapore, and other emerging markets.

Overall, increasing regulatory requirements, growing biopharmaceutical production, and technological advances are expected to support continued expansion of the global mycoplasma testing industry through 2035.

Read More
Lukoon https://lukoon.com